Title

Analyzing the Effectiveness of Vacquinol-1 on Glioblastoma Multiforme

Author(s)

Kyle JenkinsFollow

School Name

South Carolina Governor's School for Science & Mathematics

Grade Level

12th Grade

Presentation Topic

Cell and Molecular Biology

Presentation Type

Mentored

Abstract

Glioblastoma multiforme (GBM) accounts for fifty percent of all primary brain tumors. The median survival rate of GBM is ten to twelve months. Current treatments for involve apoptotic cells death, which GBM is becoming resistant to. At Clemson University, our lab analyzed the effects of an experimental, non-apoptotic drug called Vacquinol-1 (V1) on GBM.

Location

Furman Hall 107

Start Date

3-28-2020 10:00 AM

Presentation Format

Oral Only

Group Project

No

COinS
 
Mar 28th, 10:00 AM

Analyzing the Effectiveness of Vacquinol-1 on Glioblastoma Multiforme

Furman Hall 107

Glioblastoma multiforme (GBM) accounts for fifty percent of all primary brain tumors. The median survival rate of GBM is ten to twelve months. Current treatments for involve apoptotic cells death, which GBM is becoming resistant to. At Clemson University, our lab analyzed the effects of an experimental, non-apoptotic drug called Vacquinol-1 (V1) on GBM.